Deals channel feed

Black­stone's GRIN inks epilep­sy li­cens­ing deal with An­geli­ni, clos­es $140M Se­ries D

4 weeks ago
Pharma

TCG's R&D ven­ture team makes a T cell en­gager deal with Shang­hai biotech

4 weeks ago
Startups
China

Up­dat­ed: Hinge Health jumped 18% on its first day as the dig­i­tal health IPO mar­ket reawak­ens

5 weeks ago
Financing
Health Tech

Sanofi makes $470M move for Vig­il's Alzheimer's drug, while an­oth­er as­set re­turns to Am­gen

5 weeks ago
Pharma

BioN­Tech in­vests £1B in grow­ing UK foot­print un­der ex­pand­ed pact with gov­ern­ment

5 weeks ago
R&D

Genen­tech ex­pands deal with mol­e­c­u­lar glue biotech Ori­o­n­is for $105M up­front

5 weeks ago
R&D

Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

5 weeks ago
Startups

Pfiz­er joins PD-1xVEGF race with $1.25B up­front to Chi­nese biotech 3SBio

Last month
China
Pharma

Retro Bio­sciences inks blood dis­or­der deal as Sam Alt­man-backed biotech seeks $1B in funds

Last month
Startups
Cell/Gene Tx

Why Re­gen­eron is buy­ing 23andMe

Last month

Re­gen­eron plans to buy 23andMe for $256M

Last month
Pharma

Bio­Marin makes Phase 3 buy, pay­ing $270M for rare dis­ease out­fit In­ozyme

Last month
Pharma

Eli Lil­ly turns to South Ko­re­an RNA edit­ing biotech for hear­ing loss in deal worth $1.3B

Last month
Startups
Cell/Gene Tx

Ex­clu­sive: Data­vant to ac­quire re­al-world da­ta spe­cial­ist Ae­tion, dou­bling life sci­ences team

Last month
AI

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

Last month
Startups
Pharma

GSK to pay $1.2B up­front to snag Boston Phar­ma’s mid-stage MASH hope

Last month
Pharma

No­vo turns to Septer­na for oral obe­si­ty med­i­cines in deal worth up to $2.2B

Last month
Pharma

Cedars-Sinai part­ners with Re­design Health to build health tech star­tups

Last month
Health Tech

Ex­clu­sive: SEC ex­pect­ed to drop in­ves­ti­ga­tion of Il­lu­mi­na's $8B Grail deal

Last month
Diagnostics
Law

Func­tion buys Ezra, cre­at­ing one-stop shop for pre­ven­tive test­ing and scans

Last month
Startups
Health Tech

Af­ter hunt for al­ter­na­tives, Kro­nos Bio se­lects Tang Cap­i­tal's Con­cen­tra for a deal

Last month

Am­i­cus grabs Dimer­ix’s rare kid­ney dis­ease drug for $30M up­front

Last month
Pharma

Teladoc buys vir­tu­al ther­a­py start­up Up­Lift for $30M

Last month
Health Tech

Up­dat­ed: No­var­tis to buy Reg­u­lus Ther­a­peu­tics for up to $1.7B

Last month
Pharma
First page Previous page 12345 Next page Last page
A service from the Financial Times